Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomet buyout endorsed by shareholders

This article was originally published in The Gray Sheet

Executive Summary

Private equity buyout of the orthopedic implant manufacturer, valued at about $11.4 billion, is approved by shareholders - with 91% voting in favor of the deal, the firm announces Sept. 5. Investment partnerships managed by The Blackstone Group, Goldman Sachs, Kohlberg Kravis Roberts and TPG are paying $46 per share for the company under the terms of a tender offer amended in June (1"The Gray Sheet" June 11, 2007, p. 9). Biomet expects the deal to close before the start of October...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025220

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel